Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 24987 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than June 25, 2012. 

Dated: April 17, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–10054 Filed 4–25–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

Cerilliant Corporation 

By Notice dated January 5, 2012, and 

published in the Federal Register on 

January 17, 2012, 77 FR 2321, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78665–2402, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

N-Ethylamphetamine (1475) ........ I 

N,N-Dimethylamphetamine (1480) I 

Aminorex (1585) ........................... I 

4-Methylaminorex (cis isomer) 

(1590).

I 

Gamma-Hydroxybutyric acid 

(2010).

I 

Methaqualone (2565) ................... I 

1-Pentyl-3-(1-naphthoyl)indole 

(7118).

I 

1-Butyl-3-(1-naphthoyl)indole 

(7173).

I 

1-[2-(4-Morpholinyl)ethyl]-3-(1- 

naphthoyl) Indole (7200).

I 

Alpha-ethyltryptamine (7249) ....... I 

5-(1,1-Dimethylheptyl)-2-[{1R,3S)- 

3-hydroxycyclohexyl]-phenol 

(7297).

I 

5-(1,1-Dimethyloctyl)-2-[{1R,3S)- 

3-hydroxycyclohexyl]-phenol 

(7298).

Lysergic acid diethylamide (7315) I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine 

(7348).

I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

Drug Schedule 

3,4,5-Trimethoxyamphetamine 

(7390).

I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

5-Methoxy-3,4- 

methylenedioxyamphetamine 

(7401).

I 

N-Hydroxy-3,4- 

methylendioxyamphetamine 

(7402).

I 

3,4-Methylendioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

4-Methoxyamphetamine (7411) ... I 

5-Methoxy-N-Ndimethyltryptamine (7431).I 

Alpha-methyltryptamine (7432) .... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

N-Benzylpiperazine (7493) ........... I 

Acetyldihydrocodeine (9051) ........ I 

Benzylmorphine (9052) ................ I 

Codeine-N-oxide (9053) ............... I 

Dihydromorphine (9145) ............... I 

Heroin (9200) ............................... I 

Hydromorphinol (9301) ................. I 

Methyldihydromorphine (9304) ..... I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Pholcodine (9314) ........................ I 

Acetylmethadol (9601) ................. I 

Allylprodine (9602) ....................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Betacetylmethadol (9607) ............ I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Hydroxypethidine (9627) .............. I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) .................. I 

Trimeperidine (9646) .................... I 

Phenomorphan (9647) ................. I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

Tilidine (9750) ............................... I 

Para-Fluorofentanyl (9812) .......... I 

3-Methylfentanyl (9813) ................ I 

Alpha-Methylfentanyl (9814) ........ I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Beta-hydroxyfentanyl (9830) ........ I 

Drug Schedule 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Alpha-Methylthiofentanyl (9832) ... I 

3-Methylthiofentanyl (9833) .......... I 

Thiofentanyl (9835) ...................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Nabilone (7379) ............................ II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

1- 

Piperidinocyclohexanecarbonitrile (8603).

II 

Alphaprodine (9010) ..................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Racemethorphan (9732) .............. II 

Alfentanil (9737) ........................... II 

Sufentanil (9740) .......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a), and 

determined that the registration of 

Cerilliant Corporation to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Cerilliant Corporation to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 


tkelley on DSK3SPTVN1PROD with NOTICES
24988 Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–10041 Filed 4–25–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

ISP Freetown Fine Chemicals 

By Notice dated October 8, 2010, and 

published in the Federal Register on 

October 20, 2010, 75 FR 64746, ISP 

Freetown Fine Chemicals, 238 South 

Main Street, Assonet, Massachusetts 

02702, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Drug Schedule 

2,5–Dimethoxyamphetamine 

(7396).

I 

Amphetamine (1100) .................. II 

Phenylacetone (8501) ................ II 

The company plans to manufacture 

bulk API, for distribution to its 

customers. The bulk 

2,5-Dimethoxyamphetamine will be 

used for conversion into non-controlled 

substances. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of ISP 

Freetown Fine Chemicals, to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated ISP Freetown Fine 

Chemicals to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–10055 Filed 4–25–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

Johnson Matthey Pharma Services 

By Notice dated December 5, 2011, 

and published in the Federal Register 

on December 12, 2011, 76 FR 77257, 

Johnson Matthey Pharma Services, 70 

Flagship Drive, North Andover, 

Massachusetts 01845, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the following 

basic classes of controlled substances: 

Drug Schedule 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Hydrocodone (9193) ..................... II 

The company plans to utilize this 

facility to manufacture small quantities 

of the listed controlled substances in 

bulk and to conduct analytical testing in 

support of the company’s primary 

manufacturing facility in West Deptford, 

New Jersey. The controlled substances 

manufactured in bulk at this facility will 

be distributed to the company’s 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Johnson Matthey Pharma Services to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Johnson Matthey Pharma 

Services to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–10051 Filed 4–25–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

Johnson Matthey Inc. 

By Notice dated November 21, 2011, 

and published in the Federal Register 

on November 29, 2011, 76 FR 73679, 

Johnson Matthey Inc., Pharmaceuticals 

Materials, 900 River Road, 

Conshohocken, Pennsylvania 19428, 

made application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Diphenoxylate (9170) ................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Methadone Intermediate (9254) ... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Johnson Matthey Inc. to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Johnson Matthey Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–10050 Filed 4–25–12; 8:45 am] 

BILLING CODE 4410–09–P 


tkelley on DSK3SPTVN1PROD with NOTICES